Top News

Isis Pharmaceuticals Gets $7.5M From Alnylam

Carlsbad-based Isis Pharmaceuticals said late Monday that it has received $7.5M in a payment from Alnylam Pharmaceuticals, as part of a recent alliance between Genzyme and Alnylam. According to the biotech marker, the deal also has the potential to give it royalties on products and a portion of future milestone payments. Isis said the latest deal brings its total generates from sales and licensing of its intellectual property to "well over" $400M. About $50M of that has been generated from Isis Pharmaceuticals' collaborations with Alnylam.


 

Marketplace


 

 

Latest Headlines

Browse Issues

 
 

Keep up with all of the latest Southern California high tech news via email (it's free!)



or Cancel